Evidence map›Paper›PMID 40728048›Full record

ReviewJournal of surgical oncology2025

Surgery in Ovarian Cancer-Brazilian Society of Surgical Oncology Consensus.

Audrey Tieko Tsunoda, Ricardo Dos Reis, Renato Moretti-Marques, Glauco Baiocchi, Leonardo Martins Campbell, Angelica Nogueira Rodrigues, Fabio Fin, Carlos Eduardo Mattos da Cunha Andrade, Bruno Roberto Braga Azevedo, Rosilene Jara Reis and 11 more

Abstract readReviewConsensus Statement
PubMed Full text at PMC Publisher
In one paragraph

Review in Journal of surgical oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Audrey Tieko TsunodaPPGTS, Pontifícia Universidade Católica do Paraná/PUCPR, Curitiba, Paraná, Brazil.
Ricardo Dos ReisDepartment of Gynecologic Oncology, Barretos Cancer Hospital, Barretos, São Paulo, Brazil.ORCID https://orcid.org/0000-0002-8271-3690
Renato Moretti-MarquesDepartment of Gynecologic Oncology, Hospital Israelita Albert Einstein, São Paulo, São Paulo, Brazil.ORCID https://orcid.org/0000-0001-9997-6668
Glauco BaiocchiDepartment of Gynecologic Oncology, A.C. Camargo Cancer Center, São Paulo, São Paulo, Brazil.
Leonardo Martins CampbellSanta Lúcia Cancer Center, Brasília, Distrito Federal, Brazil.
Angelica Nogueira RodriguesDepartment of General Medicine, Federal University of Minas Gerais (UFMG), Belo Horizonte, Minas Gerais, Brazil.
Fabio FinDepartment of Gynecologic Oncology, Hospital São Vicente, Curitiba, Paraná, Brazil.
Carlos Eduardo Mattos da Cunha AndradeDepartment of Gynecologic Oncology, Barretos Cancer Hospital, Barretos, São Paulo, Brazil.
Bruno Roberto Braga AzevedoHospital São Vicente, Curitiba, Paraná, Brazil.
Rosilene Jara ReisHospital Ernesto Dornelles, Porto Alegre, Rio Grande do Sul, Brazil.
Thales Paulo BatistaDepartment of Surgery, Instituto de Medicina Integral Professor Fernando Figueira (IMIP), Recife, Pernambuco, Brazil.
Reitan RibeiroDepartment of Gynecologic Oncology, Hospital Erasto Gaertner, Curitiba, Paraná, Brazil.ORCID https://orcid.org/0000-0002-4323-3854
Deraldo FalcaoDepartment of Gynecologic Oncology, Hospital da Mulher Maria Luiza Costa dos Santos, Salvador, Bahia, Brazil.
Gustavo GuitmannBrazilian National Cancer Institute (INCA), Rio de Janeiro, Rio de Janeiro, Brazil.
Suzana Arenhart PessiniDepartment of Gynecologic Oncology, Federal University of Health Sciences of Porto Alegre (UFCSPA), Porto Alegre, Rio Grande do Sul, Brazil.
Paulo Henrique ZanvettorDepartment of Gynecologic Oncology, Aristides Maltez Hospital, Salvador, Bahia, Brazil.
João Soares NunesInstituto de Oncologia do Paraná, Curitiba, Paraná, Brazil.
José Clemente LinharesDepartment of Gynecologic Oncology, Hospital Erasto Gaertner, Curitiba, Paraná, Brazil.
José Augusto BelottiBrazilian National Cancer Institute (INCA), Rio de Janeiro, Rio de Janeiro, Brazil.
Alexandre OliveiraFederal University of Juiz de Fora (UFJF), Juiz de Fora, Minas Gerais, Brazil.
Rodrigo Nascimento PinheiroBrazilian Society of Surgical Oncology (SBCO), Copacabana, Rio de Janeiro, Brazil.ORCID https://orcid.org/0000-0002-2715-7628

Funding

The authors received no specific funding for this work.
6 · The paper itself

Abstract

Surgical management in epithelial ovarian cancer (EOC) has a significant impact on overall survival (OS) and progression-free survival (PFS). The Brazilian Society of Surgical Oncology (BSSO) supported an expert-led task force for consensus: the best EOC surgery is provided by experienced and specialized trained surgeons in cancer centers. Laparoscopic or radiological staging can predict the possibility of complete cytoreduction (CC0) and help to reduce unnecessary laparotomies. Carcinomatosis and nodal extension should be evaluated at imaging. Multidisciplinary input is essential for determining the need for the selection of patients for surgery and adjuvant chemotherapy in patients with EOC. The BSSO proposes quality assurance criteria and the need for national consensus. Genetic counseling was deemed mandatory for all patients with EOC. This consensus states the final recommendations from BSSO for the management of EOC.

Indexed as

Carcinoma, Ovarian EpithelialOvarian NeoplasmsSurgical OncologyBrazilCytoreduction Surgical ProceduresFemaleHumansSocieties, MedicalBrazilian Society of Surgical Oncologyconsensusepithelial ovarian cancersurgery

Identifiers

PMID40728048
PMCPMC12455541

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.